Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients

Author： Wolters R.   Wöckel A.   Janni W.   Novopashenny I.   Ebner F.   Kreienberg R.   Wischnewsky M.   Schwentner L.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.142, Iss.3, 2013-12, pp. : 579-590

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study

By Sawaki Masataka  

Breast Cancer, Vol. 19, Iss. 3, 2012-07 ,pp. : 253-258

Springer Publishing Company

Access to resources Recommend Favorite

Male breast cancer: A retrospective study comparing survival with female breast cancer

By        

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 642-646

Spandidos Publications

Access to resources Recommend Favorite

Impact of adjuvant chemotherapy delay on survival in cancer breast patients

By Ghany Dalia  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 1, 2013-01 ,pp. : 20-24

Springer Publishing Company

Access to resources Recommend Favorite

Impact of radiation therapy on survival in patients with triplenegative breast cancer

By        

Oncology Letters, Vol. 7, Iss. 2, 2014-01 ,pp. : 548-552

Spandidos Publications

Access to resources Recommend Favorite

Postoperative Adjuvant Randomised Trial Comparing Chemoendocrine Therapy, Chemotherapy and Immunotherapy for Patients with Stage II Breast Cancer: 5-year Results from The Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan

By Morimoto T.   Ogawa M.   Orita K.   Sugimachi K.   Toge T.   Dohi K.   Nomura Y.   Monden Y.   Ogawa N.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 235-242

Elsevier

Access to resources Recommend Favorite